FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387497512> ?p ?o ?g. }

• W4387497512 endingPage "S210" @default.
• W4387497512 startingPage "S210" @default.
• W4387497512 abstract "The implementation of pharmacogenomic testing in clinical practise may bring improvement to antipsychotic treatment by preventing adverse events and improving treatment efficacy and compliance, therefore relieving a major cost-burden on the healthcare system. We conducted a systematic review and meta-analysis to investigate whether pharmacogenetic testing in individuals undergoing antipsychotic treatment improves clinical and economic outcomes. Several electronic databases were searched to identify relevant articles: MEDLINE (via Ovid), EMBASE (via Ovid), PsycINFO (via Ovid) and Cochrane Centrale Register of Controlled Trials. Data on the effect of pharmacogenetics testing on clinical and economic outcomes were synthesised and reported using descriptive statistics, summary tables and a narrative approach as a result of the substantial heterogeneity between the included studies. Where a meta-analysis was deemed possible, we calculated a standardised mean difference and 95% confidence interval between the pharmacogenetic-guided and treatment as usual group. In total, 14 eligible studies were included in the systematic review. Pharmacogenetics testing was generally associated with a reduction in inpatient, outpatient, and overall costs, compared to treatment as usual. A wide range of clinical outcomes were reported: adverse drug reactions, symptom severity, medication information (such as mean daily dose, number of antipsychotics prescribed), hospitalisations, polypharmacy, and physicians’ opinions of the pharmacogenetic-guided treatment. The meta-analysis did not find a statistically significant improvement in ADRs in the pharmacogenetics group compared to the treatment as usual group (UKU score SMD, 0.08; 95% CI, -0.11—0.26; p=0.42). However, there was evidence of clinical utility for studies which included antipsychotic medication when pharmacogenetic testing was conducted as part of a broader combinatorial treatment using a multigene panel. Pharmacogenetic testing to guide prescribing and dosing for antipsychotics has demonstrated significant cost-saving benefits and clinical improvements. However, this study has highlighted important gaps in the literature. To support the clinical implementation of pharmacogenetics testing into routine mental health care, studies with sufficient sample sizes that provide recommendations for patients who take antipsychotics based on a broad, multigene panel are required." @default.
• W4387497512 created "2023-10-11" @default.
• W4387497512 creator A5000858092 @default.
• W4387497512 creator A5020963016 @default.
• W4387497512 creator A5028345361 @default.
• W4387497512 creator A5031493306 @default.
• W4387497512 creator A5035445659 @default.
• W4387497512 creator A5041682968 @default.
• W4387497512 creator A5049779574 @default.
• W4387497512 creator A5056051179 @default.
• W4387497512 creator A5070300981 @default.
• W4387497512 creator A5071924481 @default.
• W4387497512 creator A5081732229 @default.
• W4387497512 creator A5082502919 @default.
• W4387497512 creator A5085026250 @default.
• W4387497512 creator A5087899140 @default.
• W4387497512 creator A5089380770 @default.
• W4387497512 date "2023-10-01" @default.
• W4387497512 modified "2023-10-18" @default.
• W4387497512 title "T89. PHARMACOGENETIC TESTING TO GUIDE ANTIPSYCHOTIC TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS" @default.
• W4387497512 doi "https://doi.org/10.1016/j.euroneuro.2023.08.373" @default.
• W4387497512 hasPublicationYear "2023" @default.
• W4387497512 type Work @default.
• W4387497512 citedByCount "0" @default.
• W4387497512 crossrefType "journal-article" @default.
• W4387497512 hasAuthorship W4387497512A5000858092 @default.
• W4387497512 hasAuthorship W4387497512A5020963016 @default.
• W4387497512 hasAuthorship W4387497512A5028345361 @default.
• W4387497512 hasAuthorship W4387497512A5031493306 @default.
• W4387497512 hasAuthorship W4387497512A5035445659 @default.
• W4387497512 hasAuthorship W4387497512A5041682968 @default.
• W4387497512 hasAuthorship W4387497512A5049779574 @default.
• W4387497512 hasAuthorship W4387497512A5056051179 @default.
• W4387497512 hasAuthorship W4387497512A5070300981 @default.
• W4387497512 hasAuthorship W4387497512A5071924481 @default.
• W4387497512 hasAuthorship W4387497512A5081732229 @default.
• W4387497512 hasAuthorship W4387497512A5082502919 @default.
• W4387497512 hasAuthorship W4387497512A5085026250 @default.
• W4387497512 hasAuthorship W4387497512A5087899140 @default.
• W4387497512 hasAuthorship W4387497512A5089380770 @default.
• W4387497512 hasConcept C104317684 @default.
• W4387497512 hasConcept C118552586 @default.
• W4387497512 hasConcept C126322002 @default.
• W4387497512 hasConcept C135763542 @default.
• W4387497512 hasConcept C17744445 @default.
• W4387497512 hasConcept C177713679 @default.
• W4387497512 hasConcept C185592680 @default.
• W4387497512 hasConcept C197934379 @default.
• W4387497512 hasConcept C199539241 @default.
• W4387497512 hasConcept C2776412080 @default.
• W4387497512 hasConcept C2779473830 @default.
• W4387497512 hasConcept C2780494398 @default.
• W4387497512 hasConcept C44249647 @default.
• W4387497512 hasConcept C55493867 @default.
• W4387497512 hasConcept C55775858 @default.
• W4387497512 hasConcept C71924100 @default.
• W4387497512 hasConcept C95190672 @default.
• W4387497512 hasConceptScore W4387497512C104317684 @default.
• W4387497512 hasConceptScore W4387497512C118552586 @default.
• W4387497512 hasConceptScore W4387497512C126322002 @default.
• W4387497512 hasConceptScore W4387497512C135763542 @default.
• W4387497512 hasConceptScore W4387497512C17744445 @default.
• W4387497512 hasConceptScore W4387497512C177713679 @default.
• W4387497512 hasConceptScore W4387497512C185592680 @default.
• W4387497512 hasConceptScore W4387497512C197934379 @default.
• W4387497512 hasConceptScore W4387497512C199539241 @default.
• W4387497512 hasConceptScore W4387497512C2776412080 @default.
• W4387497512 hasConceptScore W4387497512C2779473830 @default.
• W4387497512 hasConceptScore W4387497512C2780494398 @default.
• W4387497512 hasConceptScore W4387497512C44249647 @default.
• W4387497512 hasConceptScore W4387497512C55493867 @default.
• W4387497512 hasConceptScore W4387497512C55775858 @default.
• W4387497512 hasConceptScore W4387497512C71924100 @default.
• W4387497512 hasConceptScore W4387497512C95190672 @default.
• W4387497512 hasLocation W43874975121 @default.
• W4387497512 hasOpenAccess W4387497512 @default.
• W4387497512 hasPrimaryLocation W43874975121 @default.
• W4387497512 hasRelatedWork W1492804085 @default.
• W4387497512 hasRelatedWork W1580313380 @default.
• W4387497512 hasRelatedWork W2012959970 @default.
• W4387497512 hasRelatedWork W2020348067 @default.
• W4387497512 hasRelatedWork W2060187873 @default.
• W4387497512 hasRelatedWork W2065339174 @default.
• W4387497512 hasRelatedWork W2111535578 @default.
• W4387497512 hasRelatedWork W2413616094 @default.
• W4387497512 hasRelatedWork W4319602444 @default.
• W4387497512 hasRelatedWork W46175057 @default.
• W4387497512 hasVolume "75" @default.
• W4387497512 isParatext "false" @default.
• W4387497512 isRetracted "false" @default.
• W4387497512 workType "article" @default.